Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 50K | |||||||||
| Other cash income from operating activities | ---- | ---- | ---- | ---- | --50K | ---- | ---- | ---- | ---- | ---- |
| Cash paid | 17.65%-1.97M | -23.12%-2.39M | 41.10%-1.94M | -95.31%-3.29M | 5.65%-1.69M | -26.31%-1.79M | -61.31%-1.41M | 2.34%-877.18K | 4.64%-898.16K | 58.97%-941.86K |
| Payments to suppliers for goods and services | 17.65%-1.97M | -23.12%-2.39M | 41.10%-1.94M | -95.31%-3.29M | 5.65%-1.69M | -26.31%-1.79M | -61.31%-1.41M | 2.34%-877.18K | 4.64%-898.16K | 58.97%-941.86K |
| Direct interest paid | 12.34%-7.91K | -6.34%-9.02K | ---8.48K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Direct interest received | -52.45%28.11K | -14.32%59.13K | 2,198.80%69.01K | 461.12%3K | -76.17%535 | -37.95%2.25K | -41.62%3.62K | -64.10%6.2K | -71.89%17.26K | -58.10%61.4K |
| Operating cash flow | 16.75%-1.95M | -24.42%-2.34M | 42.88%-1.88M | -101.17%-3.29M | 8.37%-1.64M | -26.47%-1.79M | -62.04%-1.41M | 1.13%-870.98K | -0.05%-880.9K | 59.04%-880.46K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 70.12%-1.24M | 72.23%-4.14M | 40.42%-14.9M | -21,895.16%-25.02M | 78.25%-113.74K | 1.31%-522.87K | 61.74%-529.79K | 11.38%-1.38M | -609.25%-1.56M | 274.97%306.84K |
| Capital expenditure reported | 69.54%-1.46M | 69.92%-4.81M | 35.74%-15.98M | -19,365.38%-24.87M | 75.57%-127.75K | 2.72%-522.87K | 67.79%-537.49K | 8.82%-1.67M | -63.12%-1.83M | -5.68%-1.12M |
| Net PPE purchase and sale | ---- | 90.65%-12.2K | -185.60%-130.48K | -426.04%-45.69K | --14.01K | ---- | ---6.59K | ---- | ---12.31K | ---- |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | -74.30%14.28K | --55.58K | ---- | ---- |
| Net other investing changes | -66.55%227.56K | -43.51%680.35K | 1,257.36%1.2M | ---104.07K | ---- | ---- | ---- | -18.39%228.22K | -80.43%279.64K | 26.06%1.43M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 70.12%-1.24M | 72.23%-4.14M | 40.42%-14.9M | -21,895.16%-25.02M | 78.25%-113.74K | 1.31%-522.87K | 61.74%-529.79K | 11.38%-1.38M | -609.25%-1.56M | 274.97%306.84K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -96.59%86.26K | -84.39%2.53M | -52.03%16.21M | 898.70%33.78M | 3.38M | 101.60%3.91M | -8.81%1.94M | 7,111.74%2.13M | 56.56%29.51K | |
| Net common stock issuance | -91.49%230.35K | -85.22%2.71M | -45.82%18.32M | 899.91%33.82M | --3.38M | ---- | 101.60%3.91M | -8.81%1.94M | 7,111.74%2.13M | -14.73%29.51K |
| Net other financing activities | 18.74%-144.09K | 91.62%-177.32K | -5,063.60%-2.12M | ---41K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -96.59%86.26K | -84.39%2.53M | -52.03%16.21M | 898.70%33.78M | --3.38M | ---- | 101.60%3.91M | -8.81%1.94M | 7,111.74%2.13M | 56.56%29.51K |
| Net cash flow | ||||||||||
| Beginning cash position | -54.47%3.3M | -7.38%7.25M | 233.02%7.82M | 227.99%2.35M | -76.31%716.32K | 187.30%3.02M | -23.03%1.05M | -18.72%1.37M | -24.44%1.68M | -47.92%2.23M |
| Current changes in cash | 21.54%-3.1M | -583.30%-3.95M | -110.55%-577.64K | 235.22%5.47M | 170.76%1.63M | -217.06%-2.31M | 726.03%1.97M | 0.03%-314.93K | 42.10%-315.04K | 73.44%-544.11K |
| End cash Position | -93.86%202.45K | -54.47%3.3M | -7.38%7.25M | 233.02%7.82M | 227.99%2.35M | -76.31%716.32K | 187.30%3.02M | -23.03%1.05M | -18.72%1.37M | -24.44%1.68M |
| Free cash from | 52.35%-3.41M | 60.21%-7.16M | 36.22%-17.99M | -1,497.30%-28.2M | 23.50%-1.77M | -18.02%-2.31M | 23.00%-1.96M | 6.74%-2.54M | -36.00%-2.72M | 37.64%-2M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |